Neuroendocrine dysfunction after chronic subdural hematoma
Introduction.
Traumatic brain injuries (TBI) are a serious health problem with a frequency of 235/100 000 persons per year (Tagliaferri et al. 2006) . The patients are endangered in an acute phase, but also due to chronic consequences. Among these belong orthopedic, neurologic, psychiatric and also endocrinological complications. The percentage of pituitary deficits after traumatic brain injury is quite high and it is estimated that this sequelae is underdiagnosed. In the metaanalysis of Schneider et al. was hypopituitarism observed in 15.4 -50% in a chronic phase after TBI (hypocorticalism in 2.6 -19.2%, hypothyroidism in 1-10%, hypogonadism in 1.9 -20% and growth hormone deficiency (GHD) in 5.9 -32.7%). After subarachnoid haemorrhage was the frequency of hypopituitarism even higher (37.5 -55%) (Schneider et al. 2007 ).
Brain injury leads to brain oedema, increased intracranial pressure, haemorhages, microinfarctions, fibrosis in hypothalamus and pituitary (Harper et al. 1986 , Salehi et al. 2007 ). In the late phase after TBI an autoimmune process in the pituitary is expected as the cause of some further hypopitutarisms (Tanriverdi et al. 2008) . Similar conditions could be expected in patients with subdural haemorrhages, where preceding trauma, compression of the brain, shift of midline structures, possible compression of nutritive arteries and veins might compromise the structures of hypothalamo -pituitary endocrine unit. For these reasons we undertook this first study focused on neuroendocrine functions in patients operated for subdural hematomas (SDH).
Patients.
We were examined prospectively -first week after surgery, after three months and after 12 months. Ten patients (8 males, mean age 75,9 ± 7,6 years, median age 78 years, range 64 -86 years, BMI 25,2 kg/m 2 , range 22,4 -30,5) were evaluated after one year after surgery for SDH only.
In 13 patients in our group a trauma as clear cause of the subdural haematoma was found. In those patients a mean interval between the trauma and diagnosis of the subdural haematoma was 42, 3 days (range 4 -110 days). Alcohol abuse was present in the history of five patients.
Methods.
The neurological status and its dynamics was evaluated before and after surgery for SDH.
Midline structures shift and thickness of SDH was evaluated on CT scans.
In the mentioned intervals was evaluated basic biochemistry (minerals, renal functions, AST, ALT, ALP, GGT, bilirubin, glycemia) and hypothalamo -pituitary endocrine functions Plasma ACTH levels were measured by IRMA kits (Brahms Diagnostica, Hennigsdorf, Germany). Sensitivity was 1.2 pg/ml. The intra-and interassay variability of all kits was less than 5.0 % and 10.0 % respectively.
As an adequate response in ACTH test was considered maximal cortisol value of 550 nmol/l (Clark et al. 1998) . In GHRH+ arginine test these cutoff levels for GHD were considered according to the patients´ body mass index (BMI): with BMI < 25 kg/m 2 a peak GH < 11 μg/l, with BMI 25-30 kg/m 2 a peak GH < 8 μg/l and with BMI > 30 kg/m 2 a peak Ho et al. 2007 ). The increase in TSH after TRH at least 6 mU/L in males and females younger than 40 years of age and 2 mU/L in older than 40 years was defined as normal. Evaluation of central hypothyroidism was based on complex evaluation of thyroid hormones and TSH values. Central hypogonadism was evaluated only in relevant situations (patients after menopause and males with peripheral hypogonadism were excluded).
Reference testosterone values in our laboratory are 9.9-28 nmol/l for men of age below 50
years. The evaluation of hypogonadism in older age is not straightforward. Although the decline of mean testosterone values with age is known, there are no generally accepted lower limits of normal values for elderly males (Wang et al. 2008 ). However there is consensus of clinically important cutoff for total testosterone of 8 nmol/l, below which symptomatic males usually benefit from testosterone replacement and we decided to use this limit for patients over 50 years in this evaluation (Wang et al. 2008 ).
Evaluation of DI and SIADH was also performed. In patients where concomitant medication could influence the results of hormonal tests, the influenced axis was not evaluated (i.e. thyroxin replacement for peripheral hypothyroidism etc.).
All the protocol was in accordance with the Declaration of Helsinki (2000) 
Statistical analysis
Statistical analysis was performed using SAS 9.2 software (SAS Institute Inc., Cary, NC, USA). The statistical results on comparing different time-points were calculated using a
Wilcoxon Signed Rank test due to non-gaussian distribution of many of analysed parameters.
Analysis of the relationship between various continuous variables was done using Spearman rank correlation coefficient. P-values were considered statistically significant at the 0.05 level.
Results
Maximal thickness of SDH and shift of the midline structures was described and quantified on preoperative CT scans. The maximal thickness of SDH was 33 mm, minimal thickness was 9 mm, mean 20 ± 6 (SD) mm, median 20.5 mm. Bilateral SDH was found in 11
cases. Mean shift of the midline structures in our group was 8.3 ± 5.4 mm (range 0-20 mm, median 8.8). Six patients had no shift of the midline structures -all of them had bilateral subdural hematomas.
In collaboration with neurosurgeons a neurological status was evaluated (Tab.1).
Neurological status was evaluated before the operation and again soon after the operation in a prospectively followed group. The most common finding was mild mono or hemiparesis diagnosed in 16 patients. In 41 patients the operation led to complete restitution of the neurological deficit, in 8 patients was the reparation partial.
Individual evaluation of hormonal status ( Table 2).
Evaluation of hormonal status immediately after surgery did not find any hypocortisolism, hypothyroidism nor diabetes insipidus. In 23 patients was the dynamic test in agreement with the diagnosis of GHD and in 9 cases central hypogonadism was present.
At 3 months´ evaluation we found a subnormal response of cortisol in ACTH test (maximal cortisol value was slightly below 500 nmol/l) in 2 patients, but control tests one month later showed a normal response. Central hypogonadism was present in two patients.
Response of GH in GHRH+ arginine test was insufficient in 16 cases.
At 12 months (analysed both groups -prospective and retrospective) was no hypocortisolism nor hypothyroidism diagnosed, 3 patients were hypogonadal and 15 had GHD. There was no case of DI nor SIADH in any phase of the study.
Both hypogonadism and GHD was present in 7 patients in an acute phase, 1 after 3 months (the second hypogonadal patient refused GHRH+arginine test) and in 2 patients after a year.
Head trauma as a clear cause of subdural hematoma was present in the history of 13 patients. In two of these patients was GHD present permanently and in four other was GHD and/or hypogonadism present transiently.
There was a problematic compliance during the study period in some patients and it increased with time. Although we contacted all the patients, only part of them agreed with repeated examination. Some non-compliant SDH patients did not feel health problems and others suffered from some other concomitant disease and refused further examination after 3 and 12 months. This is the first study focused on patients with chronic subdural hematoma in which we prospectively evaluated neuroendocrine functions during one year after evacuation of SDH. We did not observe in our cohort during the whole study any serious dysfunction of adrenocortical nor thyroid axes and no diabetes insipidus nor SIADH, except of two cases of subnormal cortisol response in ACTH test in 3 months´ testing. These two patients had maximal stimulated cortisol slightly below 500 nmol/l, but in a control test one month later was the response again normal.
Analysis of the hormonal status of the whole group (Table 3).

Statistical analysis of the maximal response of GH in GHRH+arginine test
Slight, but significant increase of mean basal cortisol first week after surgery could be simply a marker of stress.
Similarly to TBI studies we observed quite frequently dysfunction in gonadotrophic axis and growth hormone secretion, especially in an acute phase. Growth hormone deficiency according to GHRH+arginine test was the most frequent in our group. Recovery of gonadotrophin secretion after the acute phase appeared in the majority of patients. The time course of central hypogonadism was recently exactly described in an acute phase after brain trauma. Study of Wagner et al. revealed that within 10 days of complicated mild, moderate, and severe TBI, testosterone suppression occured in all men and estrogen suppression occured in over 40% of women (Wagner et al. 2010 ).
Chronic subdural hematoma most frequently occurs in older males (Kanat et al. 2010 ).
We are aware that evaluation of gonadotrophin axis and especially of GH secretion, in our cohort with a mean age of 68 years is rather complicated. The activity of both axes declines with age and is influenced by non-endocrine factors like for instance comorbidities, obesity etc. It is likely that function of gonadotrophic axis is a marker of general health (Araujo et al. 2011) . Establishing in this group of patients with various comorbidities the diagnosis of GHD and hypogonadism caused strictly by SDH is sometimes impossible. Replacement therapy of these axes in older people is for the mentioned reasons also limited. Nevertheless not all patients were of advanced age. Evaluating patients younger than 60 years of age there was GHD in an acute phase in 4/14 (GHD/evaluated patients under 60), after 3 months 3/10 and after 12 months in 2/8 patients. In one 36 years old patient with confirmed severe GHD was GH replacement commenced.
We also analysed the relationship between extension of SDH or clinical severity and development of hypopituitarism, but we did not find any association. From our results it is not possible to select patients more susceptible to hypopituitarism after SDH on the basis of clinical status nor CT scan.
Comparing results in our cohort with TBI or SAH studies is complicated by substantially higher age and more confounding comorbidities in our group. Nevertheless it is obvious that we observed less severe neuroendocrine dysfunction after SDH than it was published after TBI. In a prospective study after TBI had subnormal cortisol response 16% of patients in an acute phase and 18% after 6 and 12 months and hypothyroidism was present in 2% (Agha et al. 2005 (Heather et al. 2011) .
We think that patients with SDH, especially those with head trauma in the history, should be managed like patients with mild TBI (Tanriverdi et al. 2010b ). Despite we did not find any hypocortisolism in our cohort, we are aware of limited cohort of our patients and we believe that an evaluation of ACTH axis should be done in an acute phase on clinical basis and measurement of basal cortisol. Measurement of free thyroid hormones should be done in this phase also. In the chronic phase all the pituitary hormones and hormones of regulated glands should be measured and in clinical context using of appropriate dynamic tests should be considered.
In conclusion, results of our study showed no serious hypocortisolism, hypothyroidism, diabetes insipidus nor SIADH in patients operated for chronic subdural hematoma. Severe GHD was present in less than half of patients. Central hypogonadism was diagnosed in a quarter of patients in an acute phase, but recovered in the majority of them during the follow up. The possibility of neuroendocrine dysfunction should be considered in patients with SDH, although the deficits are less frequent than in patients after TBI or SAH. 
